Probiotic Supplementation IN NAFLD Patients

• Status: Completed
• Trial end date: 2023-03-01
• Target enrollment: 0
• Participant gender: All

Summary

this study aimed to evaluate the effectiveness of Probiotics supplementation (lactobacillus) on NAFLD fibrosis score.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University

Criteria

Inclusion Criteria:

• Age between18 and 60

• BMI ≥ 25 kg/m2

• Sonographic findings of NAFLD +/- elevated liver enzymes (not more than 2 folds increase).

Exclusion Criteria:

• ▪ Any evidence of chronic liver diseases including viral hepatitis (B and C), auto immune hepatitis.

• History of alcohol drinking.

• Chronic medication use (drugs that cause elevated liver enzymes, recent antibiotic use or paracetamol use in the last month)

• Persistent elevation of liver enzymes for 3 months.

• History of DM.

• History of statin therapy for cardiovascular disease (CVD).

• History of recent operation.

• History of gastroenteritis or diarrhea in the last 2 week.